Analysis Version
v1
History
Back
causal
Analysis v1
Supported

Taking a drug called evolocumab can lower the chance of having a first major heart problem by 25% in people at high risk who’ve never had a heart attack or stroke before.

95
Pro
55
Against

Evidence from Studies

Supporting (3)

95

Community contributions welcome

95

Evolocumab in Patients without a Previous Myocardial Infarction or Stroke.

Randomized Controlled Trial
Human
2026 Jan 8

The study tested evolocumab in high-risk patients who hadn’t had a heart attack or stroke and found it reduced their risk of having one by 25%, just like the claim says.

74

Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis

Randomized Controlled Trial
Human
2020 May

The study tested evolocumab in high-risk patients and found it lowered the chance of heart and stroke problems, including in people who hadn’t had one before. The results support the idea that it reduces risk by about 25%.

55

Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes

Randomized Controlled Trial
Human
2026 Mar 28

The study tested evolocumab in high-risk patients with diabetes but no prior heart attack or stroke, and found it reduced heart problems by about 31%, which is even better than the claimed 25%.

Contradicting (1)

55

Community contributions welcome

55

Rationale and Design of the Effect of EVolocumab in PatiEntS at High CArdiovascuLar RIsk WithoUt Prior Myocardial Infarction or Stroke (VESALIUS-CV) Trial.

Randomized Controlled Trial
Human
2024 Mar

The study is testing whether evolocumab helps prevent heart problems in high-risk patients who haven’t had a heart attack or stroke, but the results aren’t ready yet, so we can’t say if it really cuts risk by 25%.

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Similar Assertions

For people with heart disease who are already taking cholesterol-lowering drugs but still have high bad cholesterol, adding a drug called evolocumab can cut their risk of heart attack, stroke, or dying from heart problems by 20% over about two years.

74
0
86%

Taking a cholesterol drug called evolocumab to get really low LDL levels doesn’t seem to cause serious side effects like memory problems, diabetes, cataracts, or brain bleeds over 3 years, according to a major study.

1
0
82%

These cholesterol drugs can cut bad cholesterol by half and help prevent heart attacks in people with heart disease, and they’re about as safe as a dummy shot—though some might get a little redness where they’re injected.

1
0
82%

For people with heart disease who are on cholesterol-lowering drugs, adding a drug called evolocumab doesn’t raise their risk of serious side effects like diabetes or memory problems — the only real downside is a slightly higher chance of soreness at the injection site.

74
0
81%

For people with clogged arteries who are already taking cholesterol drugs, adding a medicine called evolocumab can help lower their chance of having a stroke.

74
0
80%

Related Content